Home › Marginal Zone Lymphoma › California › San Francisco
Marginal Zone Lymphoma clinical trials in San Francisco, CA
3 studies for Marginal Zone Lymphoma are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RecruitingPhase 1
- University of California, San Francisco, San Francisco
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
RecruitingPhase 1
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, San Francisco
Marginal Zone Lymphoma trials in other cities
- Durham, NC12 studies
- New York City, NY11 studies
- Seattle, WA9 studies
- Milwaukee, WI9 studies
- Boston, MA9 studies
- Baldwin Park, CA9 studies
- Rochester, MN8 studies
- Edison, NJ8 studies
- Columbus, OH8 studies
- Houston, TX8 studies
- Miami, FL7 studies
- Denver, CO7 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer23 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.